Home » Clinical Trials » Search Clinical Trials

Last updated on October 2018

Study of Adjuvant ONO-4538 With Resected Gastric Cancer

Brief description of study

The purpose of study is to evaluate the efficacy and safety of postoperative adjuvant chemotherapy with Nivolumab in combination with tegafur-gimeracil-oteracil potassium (S-1 therapy) or capecitabine + oxaliplatin (CapeOX therapy), in comparison with placebo in combination with S-1 therapy or CapeOX therapy, in pStage III gastric cancer (including esophagogastric junction cancer) after D2 or more extensive lymph node dissection.

Clinical Study Identifier: NCT03006705

Start Over

Aichi Clinical Site2

Nagoya, Japan

Ehime Clinicla Site

Matsuyama, Japan

Hokkaido Clinical Site

Hakodate, Japan

Hokkaido Clinical Site

Sapporo, Japan

Hyogo Clinical Site

Akashi, Japan

Hyogo Clinical Site

Nishinomiya, Japan

Iwate Clinical Site

Morioka, Japan

Kanagawa Clinical Site

Sagamihara, Japan

Kanagawa Clinical Site

Yokohama, Japan

Okayama Clinical Site

Kurashiki, Japan

Osaka Clinical Site

Suita, Japan

Osaka Clinical Site

Takatsuki, Japan

Saitama Clinical Site

Hidaka, Japan

Saitama Clinical Site

Kitaadachi-gun, Japan

Shizuoka Clinical Site

Sunto-gun, Japan

Tochigi Clinical Site

Shimotsuke, Japan

Tokyo Clinical Site

Bunkyo-ku, Japan

Tokyo Clinical Site

Chuo-ku, Japan

Tokyo Clinical Site

Koto-ku, Japan

Tokyo Clinical Site

Shinjuku-ku, Japan

Chiba Clinical Site

Chiba, Japan

Fukuoka Clinical Site

Fukuoka, Japan

Gifu Clinical Site

Gifu, Japan

Hiroshima Clinical Site1

Hiroshima, Japan

Hiroshima Clinical Site2

Hiroshima, Japan

Kochi Clinical Site

Kochi, Japan

Kumamoto Clinical Site

Kumamoto, Japan

Kyoto Clinical Site

Kyoto, Japan

Niigata Clinical Site

Niigata, Japan

Osaka Clinical Site1

Osaka, Japan

Osaka Clinical Site2

Osaka, Japan

Osaka Clinical Site3

Osaka, Japan

Shizuoka Clinical Site

Shizuoka, Japan

Toyama Clinical Site

Toyama, Japan

Wakayama Clinical Site

Wakayama, Japan

Yamagata Clinical Site

Yamagata, Japan

Busan Clinical Site1

Busan, Korea, Republic of

Busan Clinical Site2

Busan, Korea, Republic of

Daegu Clinical Site1

Daegu, Korea, Republic of

Daegu Clinical Site2

Daegu, Korea, Republic of

Daegu Clinical Site3

Daegu, Korea, Republic of

Gwangju Clinical Site

Gwangju, Korea, Republic of

Gyeonggi-do Clinical Site1

Gyeonggi-do, Korea, Republic of

Gyeonggi-do Clinical Site2

Gyeonggi-do, Korea, Republic of

Gyeonggi-do Clinical Site3

Gyeonggi-do, Korea, Republic of

Gyeonggi-do Clinical Site4

Gyeonggi-do, Korea, Republic of

Jeollabuk-do Clinical Site

Jeollabuk-do, Korea, Republic of

Seoul Clinical Site1

Seoul, Korea, Republic of

Seoul Clinical Site2

Seoul, Korea, Republic of

Seoul Clinical Site3

Seoul, Korea, Republic of

Seoul Clinical Site4

Seoul, Korea, Republic of

Seoul Clinical Site5

Seoul, Korea, Republic of

Seoul Clinical Site6

Seoul, Korea, Republic of

Seoul Clinical Site7

Seoul, Korea, Republic of

Kaohsiung Clinical Site

Kaohsiung, Taiwan

New Taipei Clinical Site

New Taipei, Taiwan

Taichung Clinical Site

Taichung, Taiwan

Tainan Clinical Site

Tainan, Taiwan

Taipei Clinical Site1

Taipei, Taiwan

Taipei Clinical Site2

Taipei, Taiwan

Aichi Clinical Site1

Nagoya, Japan

Anhui Province Clinical Site

Anhui Province, China

Beijing Clinical Site1

Beijing, China

Beijing Clinical Site2

Beijing, China

Cuangdong Province Clinical Site

Cuangdong Province, China

Jiangsu Province Clinical Site1

Jiangsu Province, China

Jiangsu Province Clinical Site3

Jiangsu Province, China

Jiangsu Province Clinical Site4

Jiangsu Province, China

Jiangsu Province Clinical Site5

Jiangsu Province, China

Shanghai Clinical Site1

Shanghai, China

Shanghai Clinical Site2

Shanghai, China

Tianjin Clinical Site1

Tianjin, China

Tianjin Clinical Site2

Tianjin, China

Zhengjiang Province Clinical Site

Zhengjiang Province, China

Guangdong Province Clinical Site1

Guangdong, China

Guangdong Province Clinical Site2

Guangdong, China

Henan Province Clinical Site1

Henan, China

Henan Province Clinical Site2

Henan, China

Jiangxi Province Clinical Site1

Jiangxi, China

Jiangxi Province Clinical Site2

Jiangxi, China

Jilin Province Clinical Site

Jilin, China

Shanxi Province Clinical Site

Shanxi, China

Zhejiang Province Clinical Site

Zhejiang, China

Chiba Clinical Site

Kamogawa, Japan

Ehime Clinical Site

Matsuyama, Japan

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.

Powered by